SM
EIGR
Sabby Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-32,190
| Closed | -$317K | – | 129 |
|
|
2018
Q1 | $317K | Sell |
32,190
-16,810
| -34% | -$166K | 0.04% | 61 |
|
|
2017
Q4 | $684K | Sell |
49,000
-43,500
| -47% | -$607K | 0.06% | 35 |
|
|
2017
Q3 | $1.02M | Sell |
92,500
-130,600
| -59% | -$1.44M | 0.07% | 20 |
|
|
2017
Q2 | $1.76M | Sell |
223,100
-15,807
| -7% | -$125K | 0.12% | 20 |
|
|
2017
Q1 | $2.74M | Sell |
238,907
-1,634
| -0.7% | -$18.7K | 0.15% | 10 |
|
|
2016
Q4 | $2.8M | Buy |
240,541
+9,738
| +4% | +$113K | 0.16% | 18 |
|
|
2016
Q3 | $3.09M | Buy |
230,803
+55,554
| +32% | +$744K | 0.12% | 17 |
|
|
2016
Q2 | $3.47M | Sell |
175,249
-84,394
| -33% | -$1.67M | 0.18% | 18 |
|
|
2016
Q1 | $4.35M | Buy |
+259,643
| New | +$4.35M | 0.22% | 15 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 213 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 185 |
|
|
2014
Q4 | – | Sell |
-71,000
| Closed | -$743 | – | 158 |
|
|
2014
Q3 | $743 | Buy |
+71,000
| New | +$743 | 0.03% | 66 |
|